State Novosibirsk Regional Clinical Hospital

The State Novosibirsk Regional Clinical Hospital was organized in 1939. As of 2018, 16 specialized centers operate on the basis of the hospital:

• Novosibirsk Interterritorial Burn Center,
• Regional Organ Donation Center,
• Regional Coloproctology Center,
• Level 1 Trauma Center,
• Regional Vascular Center No. 2,
• Regional Endocrinology Center,
• Regional Rheumatology Center,
• Regional Nephrology Center,
• Regional Center for High-Dose Chemotherapy of Hemoblastoses,
• Regional Center for Multiple Sclerosis and Other Autoimmune Diseases of the Nervous System,
• Regional Center for Neurology and Neurosurgery,
• Regional Perinatal Center,
• Regional Children's Asthma Center,
• Regional Children's Cardiorematology Center,
• Regional Children's Nephrourological Center,
• Regional Center for Laboratory Medicine.

The treatment departments of the hospital are combined into specialized clinics (therapeutic, surgical, pediatric, anesthesiology and resuscitation, obstetrics and gynecology). More than 45.0 thousand patients receive inpatient medical care in them annually, while more than 35 thousand surgical interventions are performed in the hospital per year (data as of August 2018).

The hospital is also a center for the training and advanced training of medical workers in the Novosibirsk region. The hospital staff, together with the Siberian Department of the Russian Academy of Medical Sciences and NGMU, are conducting research work on the main problems of clinical medicine.

History

2018: Charge of imposing expensive Medtronic insulin pumps on diabetic

Representatives of the DialaifSiberia public organization for combating diabetes mellitus accused the Novosibirsk Regional Clinical Hospital of imposing expensive vital devices on diabetes patients, RBC reported on August 6, 2018. In their opinion, the conditions for the purchase of such devices are written for a specific supplier.

Building of the State Novosibirsk Regional Clinical Hospital. Photo: ksonline.ru

In particular, in March 2018, the regional hospital held an auction for the supply of insulin pumps. Having studied the requirements for the supplied products set out in the documentation, social activists came to the conclusion that the procurement conditions entail limiting the number of its participants and, moreover, screening out products with better technical characteristics.

This, according to representatives of DialaifSiberia, is evidenced by a paragraph in the documentation that describes the requirements for such an important parameter of the pumps as the step of changing the basal dose of the drug, which depends on how accurately the patient can choose a dose of insulin. As follows from the documentation, the regional hospital orders devices with a step of changing the basal dose of at least 0.05 IU, while in Russia there are two pump manufacturers who offer devices with a step of 0.01 IU.

DialaifSiberia also drew attention to the parameter "monitoring the level of glikemii​ in interstitial fluid." According to representatives of the organization, this function is implemented using a separate device and is not related to the characteristics that determine the effectiveness of the insulin pump.

After analyzing the market for medical devices, social activists found that only one device manufactured by the company Medtronic , MiniMed Paradigm REAL-Time MMT-722, meets the requirements specified in the auction documentation. It is this model of insulin pump in the regional hospital that Novosibirsk residents with diabetes can offer, came to the conclusion in DialaifSiberia. Meanwhile, maintenance of Medtronic pumps costs more than 29 thousand rubles monthly, which makes them the most expensive devices on the market, the organization emphasized. As a result, patients simply cannot maintain the device and stop using it.

According to RBC, DialaifSiberia filed an appeal with the prosecutor's office, but has not yet received a response.^[1]

Insulin pump is a medical device for the administration of insulin in the treatment of diabetes mellitus. It is an alternative to multiple daily insulin injections with an insulin syringe or insulin pen and allows intensive insulin therapy when used in combination with glucose monitoring and carbohydrate count.

Notes